No chance unfortunately Rocket. We will get a few updates about safety along the way at set time points, indicating the trial can proceed, but I wouldn't expect efficacy data this year. The only real way we will be able to estimate when we will get some efficacy is when we see how recruitment is going and can predict when the trial will be fully enrolled (ANZCTR site says enrolment goal is 92 patients). They have indicated that we will get updates about recruitment along the way.
No chance unfortunately Rocket. We will get a few updates about...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
0.025(3.68%) |
Mkt cap ! $86.79M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.5¢ | 68.0¢ | $29.68K | 43.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.5¢ | 18000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
69.0¢ |
Change
0.025 ( 0.73 %) |
||||
| Open | High | Low | Volume | ||
| 68.0¢ | 69.0¢ | 68.0¢ | 9512 | ||
| Last updated 15.37pm 14/06/2024 ? | |||||
| AGN (ASX) Chart |